Valuation
- Market cap
- 0
- Revenue TTM
- $10,000
- Net income TTM
- $-8,990,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -89,900.00%
- Debt to equity
- 0.00
Trading
- Volume
- 2,100
- Avg volume
- 1,296
- Day's range
- $0.00 – $0.00
- Shares out
- 1,765,000
- Stochastic %K
- 50%
- Beta
- -26.16
- Analysts
- —
- Price target
- —
Company profile
Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and repli...
Show more
Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 778 410 5195
- Website
- https://www.lucyscientific.com
- Address
- 1321 Blanshard Street, Suite 301, Victoria, Canada
Latest news
No headlines yet.
